NDC Package 67184-1007-1 Ceftriaxone Sodium

Injection, Powder, For Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67184-1007-1
Package Description:
10 VIAL, SINGLE-USE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE
Product Code:
Proprietary Name:
Ceftriaxone Sodium
Non-Proprietary Name:
Ceftriaxone Sodium
Substance Name:
Ceftriaxone Sodium
Usage Information:
Ceftriaxone is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This drug is not recommended for use in newborns with high blood bilirubin levels and premature infants due to increased risk of side effects. Ask the doctor or pharmacist for details.
11-Digit NDC Billing Format:
67184100701
NDC to RxNorm Crosswalk:
  • RxCUI: 1665005 - cefTRIAXone 500 MG Injection
  • RxCUI: 1665005 - ceftriaxone 500 MG Injection
  • RxCUI: 1665005 - ceftriaxone 500 MG (as ceftriaxone sodium) Injection
  • RxCUI: 1665021 - cefTRIAXone 1 GM Injection
  • RxCUI: 1665021 - ceftriaxone 1000 MG Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Qilu Pharmaceutical Co., Ltd.
    Dosage Form:
    Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA203702
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    06-29-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 67184-1007-1?

    The NDC Packaged Code 67184-1007-1 is assigned to a package of 10 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use of Ceftriaxone Sodium, a human prescription drug labeled by Qilu Pharmaceutical Co., Ltd.. The product's dosage form is injection, powder, for solution and is administered via intramuscular; intravenous form.

    Is NDC 67184-1007 included in the NDC Directory?

    Yes, Ceftriaxone Sodium with product code 67184-1007 is active and included in the NDC Directory. The product was first marketed by Qilu Pharmaceutical Co., Ltd. on June 29, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 67184-1007-1?

    The 11-digit format is 67184100701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-167184-1007-15-4-267184-1007-01